Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer

Article ID	Journal	Published Year	Pages	File Type
9872504	International Journal of Radiation OncologyBiologyPhysics	2005	6 Pages	PDF

Abstract

Conclusions: Three-dimensional conformal radiotherapy, combined with paclitaxel and cisplatin chemotherapy, was associated with a satisfactory outcome with manageable toxicity. Further investigations are needed to improve the local control.

Keywords

Non-small-cell lung cancer Concurrent chemoradiotherapy Conformal radiotherapy

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer

Authors

Young Seok M.D., Sang Min M.D., Eun Kyung M.D., Ph.D., Byong Yong Ph.D., Jong Hoon M.D., Ph.D., Seung Do M.D., Ph.D., Sang-wook M.D., Ph.D., Seong Soo M.D., Jung Shin M.D., Ph.D., Cheolwon M.D., Ph.D., Sang-We M.D., Ph.D., Dong Soon M.D., Ph.D.,